- Home
- TERN vs ORGO Comparison
TERN vs ORGO Comparison
Compare TERN & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TERN
- ORGO
- Stock Information
- Founded
- TERN 2017
- ORGO 1985
- Country
- TERN United States
- ORGO United States
- Employees
- TERN N/A
- ORGO N/A
- Industry
- TERN Biotechnology: Pharmaceutical Preparations
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- TERN Health Care
- ORGO Health Care
- Exchange
- TERN Nasdaq
- ORGO Nasdaq
- Market Cap
- TERN 634.5M
- ORGO 620.3M
- IPO Year
- TERN 2021
- ORGO N/A
- Fundamental
- Price
- TERN $7.22
- ORGO $5.00
- Analyst Decision
- TERN Buy
- ORGO Buy
- Analyst Count
- TERN 6
- ORGO 2
- Target Price
- TERN $13.99
- ORGO $7.50
- AVG Volume (30 Days)
- TERN 1.2M
- ORGO 724.8K
- Earning Date
- TERN 08-05-2025
- ORGO 08-07-2025
- Dividend Yield
- TERN N/A
- ORGO N/A
- EPS Growth
- TERN N/A
- ORGO N/A
- EPS
- TERN N/A
- ORGO N/A
- Revenue
- TERN N/A
- ORGO $429,531,000.00
- Revenue This Year
- TERN N/A
- ORGO $2.57
- Revenue Next Year
- TERN N/A
- ORGO $9.80
- P/E Ratio
- TERN N/A
- ORGO N/A
- Revenue Growth
- TERN N/A
- ORGO N/A
- 52 Week Low
- TERN $1.87
- ORGO $2.46
- 52 Week High
- TERN $11.40
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- TERN 59.36
- ORGO 57.40
- Support Level
- TERN $6.78
- ORGO $4.90
- Resistance Level
- TERN $7.78
- ORGO $5.14
- Average True Range (ATR)
- TERN 0.49
- ORGO 0.23
- MACD
- TERN -0.02
- ORGO 0.01
- Stochastic Oscillator
- TERN 63.82
- ORGO 75.16
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.